US's First Cancer Vaccine

The local biotech company, Dendreon, has been approved by the FDA for treatment vaccine for men with prostate cancer. Instead of the traditional goal of preventing cancer, Provenge aims to use the immune system to attack the tumors. Any step towards cancer treatment is a milestone. Plus, go Seattle!